Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference

Rhea-AI Summary

Penumbra (NYSE: PEN) announced its management team will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025 at 12:30 PM ET/9:30 AM PT.

Investors can access the presentation through a webcast on the company's website under the "Events and Presentations" section of the "Investors" tab at www.penumbrainc.com. The webcast recording will remain available for a minimum of two weeks after the event.

News Market Reaction – PEN

-0.76%

29 alerts

-0.76% Session move

+2.7% Peak in 2 hr 43 min

$10.02B Market Cap

1.2x Rel. Volume

In the trading session that priced this news, PEN declined 0.76%, reflecting a mild negative market reaction. Argus tracked a peak move of +2.7% during that session. Our momentum scanner triggered 29 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALAMEDA, Calif., July 30, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 45^th Annual Growth Conference on Tuesday, August 12, 2025.

Event:	Canaccord Genuity 45th Annual Growth Conference
Date:	Tuesday, August 12, 2025
Time:	12:30pm ET/9:30am PT

A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.

About Penumbra 
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Investor Relations
Penumbra, Inc.
investors@penumbrainc.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-canaccord-genuity-45th-annual-growth-conference-302508918.html

SOURCE Penumbra, Inc.

FAQ

When is Penumbra (PEN) presenting at the Canaccord Genuity Growth Conference 2025?

Penumbra will present at the conference on Tuesday, August 12, 2025 at 12:30 PM ET/9:30 AM PT.

How can I watch Penumbra's (PEN) Canaccord conference presentation?

The presentation can be accessed via webcast on Penumbra's website under the "Events and Presentations" section of the "Investors" tab at www.penumbrainc.com.

How long will Penumbra's (PEN) Canaccord conference presentation be available online?

The webcast will be available on Penumbra's website for at least two weeks following the event.

What is the website address to access Penumbra's (PEN) investor presentation?

The presentation can be accessed at www.penumbrainc.com under the Investors tab.